Literature DB >> 15564513

A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.

Zhong-Min Ma1, Kristina Abel, Tracy Rourke, Yichuan Wang, Christopher J Miller.   

Abstract

In rhesus macaques, classic systemic infection, characterized by persistent viremia and seroconversion, occurred after multiple low-dose (10(3) 50% tissue culture infective doses) intravaginal (IVAG) inoculations with simian immunodeficiency virus (SIV) strain SIVmac251. Monkeys developed classic SIV infections after a variable number of low-dose IVAG exposures to SIVmac251. Once established, the systemic infection was identical to SIV infection following high-dose IVAG SIV inoculation. However, occult systemic infection characterized by transient cell-associated or cell-free viremia consistently occurred early in the series of multiple vaginal SIV exposures. Further, antiviral cellular immune responses were present prior to the establishment of a classic systemic infection in the low-dose vaginal SIV transmission model.

Entities:  

Mesh:

Year:  2004        PMID: 15564513      PMCID: PMC533914          DOI: 10.1128/JVI.78.24.14048-14052.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.

Authors:  C J Miller; M B McChesney; X Lü; P J Dailey; C Chutkowski; D Lu; P Brosio; B Roberts; Y Lu
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

Authors:  X Lü; H Kiyono; D Lu; S Kawabata; J Torten; S Srinivasan; P J Dailey; J R McGhee; T Lehner; C J Miller
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

3.  Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner.

Authors:  Nattawan Promadej; Caroline Costello; Mary M Wernett; Prasad S Kulkarni; Valerie A Robison; Kenrad E Nelson; Thomas W Hodge; Vinai Suriyanon; Ann Duerr; Janet M McNicholl
Journal:  J Infect Dis       Date:  2003-03-19       Impact factor: 5.226

Review 4.  Recent observations on HIV type-1 infection in the genital tract of men and women.

Authors:  Robert W Coombs; Patricia S Reichelderfer; Alan L Landay
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

5.  Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay.

Authors:  B L Lohman; J Higgins; M L Marthas; P A Marx; N C Pedersen
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

6.  Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group.

Authors:  C Beyrer; A W Artenstein; S Rugpao; H Stephens; T C VanCott; M L Robb; M Rinkaew; D L Birx; C Khamboonruang; P A Zimmerman; K E Nelson; C Natpratan
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

7.  Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.

Authors:  C J Miller; M Marthas; J Torten; N J Alexander; J P Moore; G F Doncel; A G Hendrickx
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.

Authors:  Tuofu Zhu; Lawrence Corey; Yon Hwangbo; Jean M Lee; Gerald H Learn; James I Mullins; M Juliana McElrath
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus.

Authors:  C J Miller; N J Alexander; S Sutjipto; A A Lackner; A Gettie; A G Hendrickx; L J Lowenstine; M Jennings; P A Marx
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.

Authors:  M B McChesney; J R Collins; D Lu; X Lu; J Torten; R L Ashley; M W Cloyd; C J Miller
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  28 in total

Review 1.  A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.

Authors:  Thomas J Hope; Jeanne M Marrazzo
Journal:  AIDS Res Hum Retroviruses       Date:  2015-11       Impact factor: 2.205

2.  Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.

Authors:  Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Hiroshi Mohri; Rudolf Bohm; Mohammed Saifuddin; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-01-29       Impact factor: 3.616

3.  Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Authors:  Silvana Tasca; Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Mohammed Saifuddin; Rudolf Bohm; Lisa Chakrabarti; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

Review 4.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

5.  SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma.

Authors:  Zhong-Min Ma; Brandon F Keele; Huma Qureshi; Mars Stone; Veronique Desilva; Linda Fritts; Jeffrey D Lifson; Christopher J Miller
Journal:  AIDS Res Hum Retroviruses       Date:  2011-07-06       Impact factor: 2.205

Review 6.  Nonhuman primate models in AIDS research.

Authors:  David T Evans; Guido Silvestri
Journal:  Curr Opin HIV AIDS       Date:  2013-07       Impact factor: 4.283

7.  Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.

Authors:  Tara R Henning; Debra Hanson; Sundaram A Vishwanathan; Katherine Butler; Charles Dobard; Gerardo Garcia-Lerma; Jessica Radzio; James Smith; Janet M McNicholl; Ellen N Kersh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10-14       Impact factor: 2.205

8.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

9.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

Authors:  Brandon F Keele; Hui Li; Gerald H Learn; Peter Hraber; Elena E Giorgi; Truman Grayson; Chuanxi Sun; Yalu Chen; Wendy W Yeh; Norman L Letvin; John R Mascola; Gary J Nabel; Barton F Haynes; Tanmoy Bhattacharya; Alan S Perelson; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

10.  Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Authors:  Kristina E Howard; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Retrovirology       Date:  2010-01-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.